Status:
RECRUITING
Postoperative Vocal Cord Palsy Between Double-lumen Endobronchial Tube and Bronchial Blocker for Robot-assisted Esophagectomy
Lead Sponsor:
Samsung Medical Center
Conditions:
One Lung Ventillation (OLV)
Eligibility:
All Genders
19+ years
Phase:
NA
Brief Summary
The goal of this clinical trial is to investigate whether the use of bronchial blocker could reduce the incidence of postoperative vocal cord palsy than the use of double-lumen endobronchial tube in r...
Detailed Description
Esophagectomy is a challenging surgery that usually requires one lung ventilation, and double-lumen endobronchial tubes and bronchial blockers are commonly used for one lung ventilation. Successful r...
Eligibility Criteria
Inclusion
- Adults aged 19 or older
- American Society of Anesthesiologists physical status I - III
- Elective robot-assisted esophagectomy
- Any clinical stage of esophageal cancer
- Patients who need recurrent laryngeal nerve lymph nodes resection
Exclusion
- Patients who diagnosed vocal cord palsy or damage before surgery
- Patients who need specific airway device due to airway problem
- History of thoracic surgery
- Emergency surgery
- Combined surgery with other department
- Pregnant or nursing women
Key Trial Info
Start Date :
April 14 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2026
Estimated Enrollment :
202 Patients enrolled
Trial Details
Trial ID
NCT06897501
Start Date
April 14 2025
End Date
December 1 2026
Last Update
May 18 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Samsung Medical Center
Seoul, South Korea, 06351